Last reviewed · How we verify

NCT05152043

Effects of Romadan Fasting on Variability in Blood Pressure in Healthy and Hypertensive Subjects

Completed Last updated 17 April 2026
What this trial tests

trial in Hypertension in 150 participants. Completed in 31 December 2024.

Timeline
1 May 2019
Primary endpoint
31 December 2024
31 December 2024

Quick facts

Lead sponsorUniversity of Monastir
StatusCompleted
Study typeOBSERVATIONAL
Enrollment150
Start date1 May 2019
Primary completion31 December 2024
Estimated completion31 December 2024
Sites1 location across Tunisia

Conditions studied

Sponsor

University of Monastir

Who can join

30 and older, any sex, with Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Included participants who have a stable HT who intend to practice RJ

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hypertension

Currently open trials in the same condition.

Other University of Monastir trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05152043.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing